Breast cancer is one of the most frequent tumors of the female population and is basically considered a disease of women. Though males do not develop milk-producing breasts, a man's breast cells and tissue can still develop cancer. Male breast cancer (MBC) is a relatively rare disease with an incidence of < 1% of all breast cancers, mostly occurring at an older age. Though rare, it carries a higher mortality than women do, primarily because awareness among men is less causing a delay in seeking treatment, secondarily due to less amount of breast tissue the spread occurs faster thus presenting with an advanced disease. Due to its rarity, MBC is not well-understood, current knowledge is based mainly on population-based or descriptive studies that assess a limited number of patients. Its optimal treatment is not known, and the general recommendation is to use current guidelines for female breast cancer. Most MBC show positivity for hormonal receptors viz.; estrogen, progesterone, and HER-2, rarely triple negative cancers are seen which are even more aggressive and difficult to treat. We report a rare case of highly aggressive and recurrent - triple negative carcinoma left breast in a 60-year-old male.